| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $274.2M | +9.8% | +38.0% |
| Cost of Revenue | $83.9M | +200.8% | +348.5% |
| Gross Profit | $190.3M | -14.2% | +5.8% |
| R&D Expense | $680.9M | +719.8% | +553.6% |
| SG&A Expense | $371.4M | +854.3% | +748.0% |
| Operating Income | -$1.14B | — | -2301.5% |
| Pre-tax Income | -$1.11B |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $340.5M | -45.2% | -18.2% |
| Short-term Investments | $1.24B | +27.3% | — |
| Accounts Receivable | $156.0M | +25.1% | — |
| Current Assets | $1.84B | +2.0% | — |
| Total Assets | $2.07B | +1.9% | — |
| Current Liabilities | $622.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $210.8M | — | — |
| Capital Expenditures | $3.7M | — | — |
| Investing Cash Flow | -$294.4M | — | — |
| Financing Cash Flow | -$55.7M | — | — |
| Free Cash Flow | $207.1M | — | — |
| -2935.8% |
| -3663.6% |
| Income Tax | -$10.5M | -196.6% | +24.4% |
| Net Income | -$1.10B | -3986.4% | -6933.0% |
| EPS (Basic) | -$2.72 | — | -3785.7% |
| EPS (Diluted) | -$2.72 | — | -3785.7% |
| +13.9% |
| — |
| Total Liabilities | $684.7M | +12.7% | — |
| Stockholders' Equity | $1.39B | -2.7% | +18.8% |